Global Ibuprofen Sales Market
Global Ibuprofen Sales Market

Ibuprofen Sales Comprehensive Study by Type (USP, EP), Form (Tablet, Capsule, Suspension, Other), Process (Intravenous, Oral) Players and Region - Global Market Outlook to 2025

Ibuprofen Sales Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Jan 2019 Edition 231 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Ibuprofen is a non steroidal anti-inflammatory drug (NSAIDs) used as a painkiller as well as for treating fever and inflammation. This medication can be available to take without doctor's prescriptions. It also pain and inflammation caused by conditions that effect joints, bones, and muscles. In addition to this, Ibuprofen also reduces migraine, toothache and others. It was initially developed in 1960 while researching for a safer alternative for aspirin.

The market study is being classified by Type (USP and EP) and major geographies with country level break-up.

Xinhua Pharmaceutical (China), IOLCP (India), Granules Biocause (China), Strides Pharma Science Limited. (India), BASF (Germany), SI Group, Inc. (United States), Xinhua-Perrigo Pharmaceutical (China), Hisoar (China), Unipex (France) and Rochem (United States) are some of the key players profiled in the study. Additionally, the Vendors which are also part of the research are Aasraw Biochemical Technology Co.ltd (China), Biotechnica Pharma Global (BPG) (Algeria), DEAFARMA (Italy), Mallinckrodt Pharmaceuticals (United States), Nishchem International Pvt. Ltd. (NIPL) (India) and Teligent, Inc. (United States).

Very seldom Ibuprofen manufacturers are available in the global market. Thus, the overall competition is on lower side.. But, some Stringent Government Regulation might pose an entry barriers. The overall medicinal market will have slight Oligopoly among the key manufacturers. Research Analyst at AMA predicts that Chinese Vendors will contribute to the maximum growth of Global Ibuprofen Sales market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Ibuprofen Sales market by Type, Application and Region.

On the basis of geography, the market of Ibuprofen Sales has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). United States region held largest market share in the year 2018. If we see Market by Form, the sub-segment i.e. Tablet will boost the Ibuprofen Sales market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Process, the sub-segment i.e. Intravenous will boost the Ibuprofen Sales market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Adoption of Painkillers in Acute Pain Conditions
  • Improving interdependence on Analgesic Medication in case of IV Ibuprofen
  • Huge demand in the market with Minimum Competition

Market Trend
  • Adoption of Ibuprofens with minimized cardiovascular side effects
  • Introduction to Ibuprofen Gel

Restraints
  • Posses Number of Side Effects including Nausea, Upsets Stomach, Vomiting, Headache, Diarrhea
  • This medication can increase the patient's blood pressure
  • Pose some serious threats to Kidney

Opportunities
  • Demand for Ibuprofen is the most as compared to its productivity
  • Opportunities in untapped markets where the government subsidies can assist in upsurging demand


On 9th August, 2018, SI Group Inc. has announced that it will be increasing its capacity for ibuprofen manufacture by 25%, to be completed by 2020.
"The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has said that patients taking ibuprofen at doses of 2,400 mg or more per day are at a higher risk of heart attack or stroke than those taking lower doses." and "Practs Committee has stated that the level of risk will not increase when taking up to 1,200 mg of ibuprofen, which is typically the highest recommended dose for OTC versions."

Key Target Audience
Ibuprofen Manufacturers, Ibuprofen Distributors Traders, Government and Private Health Care Organisations, Hospitals, Medical Institutes and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • USP
  • EP
By Form
  • Tablet
  • Capsule
  • Suspension
  • Other

By Process
  • Intravenous
  • Oral

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adoption of Painkillers in Acute Pain Conditions
      • 3.2.2. Improving interdependence on Analgesic Medication in case of IV Ibuprofen
      • 3.2.3. Huge demand in the market with Minimum Competition
    • 3.3. Market Trends
      • 3.3.1. Adoption of Ibuprofens with minimized cardiovascular side effects
      • 3.3.2. Introduction to Ibuprofen Gel
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ibuprofen Sales, by Type, Form, Process and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Ibuprofen Sales (Value)
      • 5.2.1. Global Ibuprofen Sales by: Type (Value)
        • 5.2.1.1. USP
        • 5.2.1.2. EP
      • 5.2.2. Global Ibuprofen Sales by: Form (Value)
        • 5.2.2.1. Tablet
        • 5.2.2.2. Capsule
        • 5.2.2.3. Suspension
        • 5.2.2.4. Other
      • 5.2.3. Global Ibuprofen Sales by: Process (Value)
        • 5.2.3.1. Intravenous
        • 5.2.3.2. Oral
      • 5.2.4. Global Ibuprofen Sales Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Ibuprofen Sales (Price)
      • 5.3.1. Global Ibuprofen Sales by: Type (Price)
  • 6. Ibuprofen Sales: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Xinhua Pharmaceutical (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. IOLCP (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Granules Biocause (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Strides Pharma Science Limited. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BASF (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. SI Group, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Xinhua-Perrigo Pharmaceutical (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hisoar (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Unipex (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Rochem (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Ibuprofen Sales Sale, by Type, Form, Process and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Ibuprofen Sales (Value)
      • 7.2.1. Global Ibuprofen Sales by: Type (Value)
        • 7.2.1.1. USP
        • 7.2.1.2. EP
      • 7.2.2. Global Ibuprofen Sales by: Form (Value)
        • 7.2.2.1. Tablet
        • 7.2.2.2. Capsule
        • 7.2.2.3. Suspension
        • 7.2.2.4. Other
      • 7.2.3. Global Ibuprofen Sales by: Process (Value)
        • 7.2.3.1. Intravenous
        • 7.2.3.2. Oral
      • 7.2.4. Global Ibuprofen Sales Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Ibuprofen Sales (Price)
      • 7.3.1. Global Ibuprofen Sales by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ibuprofen Sales: by Type(USD Million)
  • Table 2. Ibuprofen Sales USP , by Region USD Million (2013-2018)
  • Table 3. Ibuprofen Sales EP , by Region USD Million (2013-2018)
  • Table 4. Ibuprofen Sales: by Form(USD Million)
  • Table 5. Ibuprofen Sales Tablet , by Region USD Million (2013-2018)
  • Table 6. Ibuprofen Sales Capsule , by Region USD Million (2013-2018)
  • Table 7. Ibuprofen Sales Suspension , by Region USD Million (2013-2018)
  • Table 8. Ibuprofen Sales Other , by Region USD Million (2013-2018)
  • Table 9. Ibuprofen Sales: by Process(USD Million)
  • Table 10. Ibuprofen Sales Intravenous , by Region USD Million (2013-2018)
  • Table 11. Ibuprofen Sales Oral , by Region USD Million (2013-2018)
  • Table 12. South America Ibuprofen Sales, by Country USD Million (2013-2018)
  • Table 13. South America Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 14. South America Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 15. South America Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 16. Brazil Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 17. Brazil Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 18. Brazil Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 19. Argentina Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 20. Argentina Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 21. Argentina Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 22. Rest of South America Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 23. Rest of South America Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 24. Rest of South America Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 25. Asia Pacific Ibuprofen Sales, by Country USD Million (2013-2018)
  • Table 26. Asia Pacific Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 27. Asia Pacific Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 28. Asia Pacific Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 29. China Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 30. China Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 31. China Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 32. Japan Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 33. Japan Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 34. Japan Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 35. India Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 36. India Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 37. India Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 38. South Korea Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 39. South Korea Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 40. South Korea Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 41. Taiwan Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 42. Taiwan Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 43. Taiwan Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 44. Australia Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 45. Australia Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 46. Australia Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 47. Rest of Asia-Pacific Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 50. Europe Ibuprofen Sales, by Country USD Million (2013-2018)
  • Table 51. Europe Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 52. Europe Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 53. Europe Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 54. Germany Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 55. Germany Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 56. Germany Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 57. France Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 58. France Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 59. France Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 60. Italy Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 61. Italy Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 62. Italy Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 63. United Kingdom Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 64. United Kingdom Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 65. United Kingdom Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 66. Netherlands Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 67. Netherlands Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 68. Netherlands Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 69. Rest of Europe Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 70. Rest of Europe Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 71. Rest of Europe Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 72. MEA Ibuprofen Sales, by Country USD Million (2013-2018)
  • Table 73. MEA Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 74. MEA Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 75. MEA Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 76. Middle East Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 77. Middle East Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 78. Middle East Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 79. Africa Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 80. Africa Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 81. Africa Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 82. North America Ibuprofen Sales, by Country USD Million (2013-2018)
  • Table 83. North America Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 84. North America Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 85. North America Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 86. United States Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 87. United States Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 88. United States Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 89. Canada Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 90. Canada Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 91. Canada Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 92. Mexico Ibuprofen Sales, by Type USD Million (2013-2018)
  • Table 93. Mexico Ibuprofen Sales, by Form USD Million (2013-2018)
  • Table 94. Mexico Ibuprofen Sales, by Process USD Million (2013-2018)
  • Table 95. Ibuprofen Sales: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Ibuprofen Sales: by Type(USD Million)
  • Table 107. Ibuprofen Sales USP , by Region USD Million (2019-2024)
  • Table 108. Ibuprofen Sales EP , by Region USD Million (2019-2024)
  • Table 109. Ibuprofen Sales: by Form(USD Million)
  • Table 110. Ibuprofen Sales Tablet , by Region USD Million (2019-2024)
  • Table 111. Ibuprofen Sales Capsule , by Region USD Million (2019-2024)
  • Table 112. Ibuprofen Sales Suspension , by Region USD Million (2019-2024)
  • Table 113. Ibuprofen Sales Other , by Region USD Million (2019-2024)
  • Table 114. Ibuprofen Sales: by Process(USD Million)
  • Table 115. Ibuprofen Sales Intravenous , by Region USD Million (2019-2024)
  • Table 116. Ibuprofen Sales Oral , by Region USD Million (2019-2024)
  • Table 117. South America Ibuprofen Sales, by Country USD Million (2019-2024)
  • Table 118. South America Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 119. South America Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 120. South America Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 121. Brazil Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 122. Brazil Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 123. Brazil Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 124. Argentina Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 125. Argentina Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 126. Argentina Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 127. Rest of South America Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 128. Rest of South America Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 129. Rest of South America Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 130. Asia Pacific Ibuprofen Sales, by Country USD Million (2019-2024)
  • Table 131. Asia Pacific Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 132. Asia Pacific Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 133. Asia Pacific Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 134. China Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 135. China Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 136. China Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 137. Japan Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 138. Japan Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 139. Japan Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 140. India Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 141. India Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 142. India Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 143. South Korea Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 144. South Korea Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 145. South Korea Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 146. Taiwan Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 147. Taiwan Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 148. Taiwan Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 149. Australia Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 150. Australia Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 151. Australia Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 152. Rest of Asia-Pacific Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 153. Rest of Asia-Pacific Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 154. Rest of Asia-Pacific Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 155. Europe Ibuprofen Sales, by Country USD Million (2019-2024)
  • Table 156. Europe Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 157. Europe Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 158. Europe Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 159. Germany Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 160. Germany Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 161. Germany Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 162. France Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 163. France Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 164. France Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 165. Italy Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 166. Italy Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 167. Italy Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 168. United Kingdom Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 169. United Kingdom Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 170. United Kingdom Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 171. Netherlands Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 172. Netherlands Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 173. Netherlands Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 174. Rest of Europe Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 175. Rest of Europe Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 176. Rest of Europe Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 177. MEA Ibuprofen Sales, by Country USD Million (2019-2024)
  • Table 178. MEA Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 179. MEA Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 180. MEA Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 181. Middle East Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 182. Middle East Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 183. Middle East Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 184. Africa Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 185. Africa Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 186. Africa Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 187. North America Ibuprofen Sales, by Country USD Million (2019-2024)
  • Table 188. North America Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 189. North America Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 190. North America Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 191. United States Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 192. United States Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 193. United States Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 194. Canada Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 195. Canada Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 196. Canada Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 197. Mexico Ibuprofen Sales, by Type USD Million (2019-2024)
  • Table 198. Mexico Ibuprofen Sales, by Form USD Million (2019-2024)
  • Table 199. Mexico Ibuprofen Sales, by Process USD Million (2019-2024)
  • Table 200. Ibuprofen Sales: by Type(USD/Units)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ibuprofen Sales: by Type USD Million (2013-2018)
  • Figure 5. Global Ibuprofen Sales: by Form USD Million (2013-2018)
  • Figure 6. Global Ibuprofen Sales: by Process USD Million (2013-2018)
  • Figure 7. South America Ibuprofen Sales Share (%), by Country
  • Figure 8. Asia Pacific Ibuprofen Sales Share (%), by Country
  • Figure 9. Europe Ibuprofen Sales Share (%), by Country
  • Figure 10. MEA Ibuprofen Sales Share (%), by Country
  • Figure 11. North America Ibuprofen Sales Share (%), by Country
  • Figure 12. Global Ibuprofen Sales: by Type USD/Units (2013-2018)
  • Figure 13. Global Ibuprofen Sales share by Players 2018 (%)
  • Figure 14. Global Ibuprofen Sales share by Players (Top 3) 2018(%)
  • Figure 15. Global Ibuprofen Sales share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Xinhua Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 18. Xinhua Pharmaceutical (China) Revenue: by Geography 2018
  • Figure 19. IOLCP (India) Revenue, Net Income and Gross profit
  • Figure 20. IOLCP (India) Revenue: by Geography 2018
  • Figure 21. Granules Biocause (China) Revenue, Net Income and Gross profit
  • Figure 22. Granules Biocause (China) Revenue: by Geography 2018
  • Figure 23. Strides Pharma Science Limited. (India) Revenue, Net Income and Gross profit
  • Figure 24. Strides Pharma Science Limited. (India) Revenue: by Geography 2018
  • Figure 25. BASF (Germany) Revenue, Net Income and Gross profit
  • Figure 26. BASF (Germany) Revenue: by Geography 2018
  • Figure 27. SI Group, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. SI Group, Inc. (United States) Revenue: by Geography 2018
  • Figure 29. Xinhua-Perrigo Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 30. Xinhua-Perrigo Pharmaceutical (China) Revenue: by Geography 2018
  • Figure 31. Hisoar (China) Revenue, Net Income and Gross profit
  • Figure 32. Hisoar (China) Revenue: by Geography 2018
  • Figure 33. Unipex (France) Revenue, Net Income and Gross profit
  • Figure 34. Unipex (France) Revenue: by Geography 2018
  • Figure 35. Rochem (United States) Revenue, Net Income and Gross profit
  • Figure 36. Rochem (United States) Revenue: by Geography 2018
  • Figure 37. Global Ibuprofen Sales: by Type USD Million (2013-2018)
  • Figure 38. Global Ibuprofen Sales: by Form USD Million (2013-2018)
  • Figure 39. Global Ibuprofen Sales: by Process USD Million (2013-2018)
  • Figure 40. South America Ibuprofen Sales Share (%), by Country
  • Figure 41. Asia Pacific Ibuprofen Sales Share (%), by Country
  • Figure 42. Europe Ibuprofen Sales Share (%), by Country
  • Figure 43. MEA Ibuprofen Sales Share (%), by Country
  • Figure 44. North America Ibuprofen Sales Share (%), by Country
  • Figure 45. Global Ibuprofen Sales: by Type USD/Units (2013-2018)
Some of the key companies/manufacturers profiled in the report
  • Xinhua Pharmaceutical (China)
  • IOLCP (India)
  • Granules Biocause (China)
  • Strides Pharma Science Limited. (India)
  • BASF (Germany)
  • SI Group, Inc. (United States)
  • Xinhua-Perrigo Pharmaceutical (China)
  • Hisoar (China)
  • Unipex (France)
  • Rochem (United States)
Additional players considered in the study are as follows:
Aasraw Biochemical Technology Co.ltd (China) , Biotechnica Pharma Global (BPG) (Algeria) , DEAFARMA (Italy) , Mallinckrodt Pharmaceuticals (United States) , Nishchem International Pvt. Ltd. (NIPL) (India) , Teligent, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation